Hosted on MSN

UPSC NDA, CDS application window opens: Direct link to apply and other key details here

UPSC NDA, CDS application form 2025: The Union Public Service Commission (UPSC) has officially activated the application link for the National Defence Academy and Naval Academy Examination (NDA/NA II) ...
jagranjosh.com

UPSC NDA Registration 2025 Ends Today, Application Form Link Active Now at upsc.gov.in

UPSC NDA (I) Application Form 2026: Those who are seeking a career in the three Army Wings can apply for the National Defence Academy (NDA) application form 2026 at upsconline.nic.in. It is advisable ...
Indiatimes

UPSC NDA and CDS registration window 2025 closing tomorrow: Direct links to apply here

UPSC CDS and NDA application process 2025: The Union Public Service Commission will close the registration window for UPSC NDA and CDS 2026 tomorrow, December 30, 2025, at 6:00 PM. Applications ...
Business Insider

X4 Pharmaceuticals Announces Submission of New Drug Application (NDA) to U.S. FDA for Mavorixafor in WHIM Syndrome

BOSTON, Sept. 05, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced the submission of ...
Hosted on MSN

UPSC NDA NA 2, CDS 2 Exam 2025: Application Correction Window Closes Tomorrow At upsconline.nic.in- Check Direct Link, Steps To Make Corrections Here

USPC Exam 2025: The Union Public Service Commission (UPSC) will close the correction window for the National Defence Academy & Naval Academy (NDA & NA II) and Combined Defence Services (CDS II) ...
Morningstar

TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 - The World's First Apixaban Oral Dissolving Film - Represents a Transformational ...

TAIPEI, Oct. 1, 2025 /PRNewswire/ -- TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...
Insider Monkey

Ocular Therapeutix (OCUL) Hits 4-Year High on Axpaxli NDA Application

We recently published 10 Stocks Standing Tall Amid Market Fall; 6 Hit Record Highs. Ocular Therapeutix, Inc. (NASDAQ:OCUL) is one of the best performers on Monday. Ocular Therapeutix surged to a new ...
Morningstar

Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)

NDA Includes 52-Week Data from Phase 3 VERIFY Study, Which Met the Primary and All Four Key Secondary Endpoints, Showing Rusfertide Provided Durable and Sustained Hematocrit Control and Improved ...